Literature DB >> 11050463

Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.

T Tsujiuchi1, Y Sasaki, M Tsutsumi, Y Konishi.   

Abstract

The expression of interleukins (ILs) in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine (BHP) in rats was investigated using a multiprobe RNase protection assay (RPA) followed by densitometric quantification. Male Wistar rats, 6 weeks old, were given 2000 ppm BHP in their drinking water for 12 weeks and maintained without further treatment until they were killed at week 25. Total RNAs were extracted from 14 individual adenocarcinomas and 2 specimens of normal lung tissue of untreated rats. In adenocarcinomas, elevated expression of IL-1alpha (6 / 14), IL-1beta (14 / 14), IL-3 (7 / 14), IL-4 (11 / 14), IL-5 (9 / 14), IL-6 (11 / 14) and IL-10 (8 / 14) was observed, compared with normal lung tissues. In contrast, no expression of IL-2 was detected in any case. The results suggest that preferential expression of these ILs and their complex networks may contribute to the development and progression of lung adenocarcinomas induced by BHP in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050463      PMCID: PMC5926255          DOI: 10.1111/j.1349-7006.2000.tb00870.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  41 in total

Review 1.  Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.

Authors:  S D Hursting; T J Slaga; S M Fischer; J DiGiovanni; J M Phang
Journal:  J Natl Cancer Inst       Date:  1999-02-03       Impact factor: 13.506

2.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

Review 3.  Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease.

Authors:  S Romagnani
Journal:  Int J Clin Lab Res       Date:  1991

Review 4.  Lymphocyte responses and cytokines.

Authors:  W E Paul; R A Seder
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

5.  Overexpression of midkine in lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats and its increase with progression.

Authors:  H Sakitani; M Tsutsumi; K Kadomatsu; S Ikematsu; M Takahama; K Iki; T Tsujiuchi; T Muramatsu; S Sakuma; T Sakaki; Y Konishi
Journal:  Carcinogenesis       Date:  1999-03       Impact factor: 4.944

Review 6.  Interleukin-3 and hematopoiesis.

Authors:  J N Ihle
Journal:  Chem Immunol       Date:  1992

7.  Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2.

Authors:  L Chen; Y Mory; A Zilberstein; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in rats.

Authors:  M Takahama; M Tsutsumi; T Tsujiuchi; A Kido; H Sakitani; K Iki; S Taniguchi; S Kitamura; Y Konishi
Journal:  Mol Carcinog       Date:  1999-04       Impact factor: 4.784

9.  Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients.

Authors:  C Asselin-Paturel; H Echchakir; G Carayol; F Gay; P Opolon; D Grunenwald; S Chouaib; F Mami-Chouaib
Journal:  Int J Cancer       Date:  1998-07-03       Impact factor: 7.396

10.  Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.

Authors:  S B Jakowlew; A Mathias; P Chung; T W Moody
Journal:  Cell Growth Differ       Date:  1995-04
View more
  1 in total

1.  Multiple berry types prevent N-nitrosomethylbenzylamine-induced esophageal cancer in rats.

Authors:  Gary D Stoner; Li-Shu Wang; Claire Seguin; Claudio Rocha; Kristen Stoner; Steven Chiu; A Douglas Kinghorn
Journal:  Pharm Res       Date:  2010-03-16       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.